Status Quo and Analysis of the Cardiovascular Clinical Practice Guidelines/Expert Consensuses of Chinese and Integrative Medicine: A Systematic Review*

Cheng-yu LI; Yao-long CHEN; Jia-yuan HU; Min LI; Xiao-yu ZHANG; Yang SUN; Rui ZHENG; Shi-qi CHEN; Song-jie HAN; Tian-mai HE; Hong-cai SHANG

doi:10.1007/s11655-020-2725-3

Your Location：

Home >

Browse articles >

Status Quo and Analysis of the Cardiovascular Clinical Practice Guidelines/Expert Consensuses of Chinese and Integrative Medicine: A Systematic Review*

Evidence-Based Integrative Medicine | Updated：2021-08-16

- Status Quo and Analysis of the Cardiovascular Clinical Practice Guidelines/Expert Consensuses of Chinese and Integrative Medicine: A Systematic Review*
- Status Quo and Analysis of the Cardiovascular Clinical Practice Guidelines/Expert Consensuses of Chinese and Integrative Medicine: A Systematic Review*
- Chinese Journal of Integrative Medicine 2021年27卷第1期页码：54-61
- Affiliations：
  
  1.Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing (100700), China
  2.Evidence-Based Medicine Center, Lanzhou University, Lanzhou (730000),China
- Author bio：
  
  Correspondence to: Prof. SHANG Hong-cai, E-mail:shanghongcai@126.com.
- Funds：
  
  the National Key R&D Program of China
- DOI：10.1007/s11655-020-2725-3
  中图分类号：
- 纸质出版日期：2021-01-01，
  
  网络出版日期：2020-05-22，
  
  录用日期：2018-06-01
Scan for full text
Cheng-yu LI, Yao-long CHEN, Jia-yuan HU, 等. Status Quo and Analysis of the Cardiovascular Clinical Practice Guidelines/Expert Consensuses of Chinese and Integrative Medicine: A Systematic Review*[J]. Chinese Journal of Integrative Medicine, 2021,27(1):54-61.

Cheng-yu LI, Yao-long CHEN, Jia-yuan HU, et al. Status Quo and Analysis of the Cardiovascular Clinical Practice Guidelines/Expert Consensuses of Chinese and Integrative Medicine: A Systematic Review*[J]. Chinese Journal of Integrative Medicine, 2021,27(1):54-61.
Cheng-yu LI, Yao-long CHEN, Jia-yuan HU, 等. Status Quo and Analysis of the Cardiovascular Clinical Practice Guidelines/Expert Consensuses of Chinese and Integrative Medicine: A Systematic Review*[J]. Chinese Journal of Integrative Medicine, 2021,27(1):54-61. DOI： 10.1007/s11655-020-2725-3.

Cheng-yu LI, Yao-long CHEN, Jia-yuan HU, et al. Status Quo and Analysis of the Cardiovascular Clinical Practice Guidelines/Expert Consensuses of Chinese and Integrative Medicine: A Systematic Review*[J]. Chinese Journal of Integrative Medicine, 2021,27(1):54-61. DOI： 10.1007/s11655-020-2725-3.

摘要

Abstract

Objective:

To describe and analyze the status quo of cardiovascular clinical practice guidelines or expert consensuses including both Chinese medicine (CM) and integrative medicine

through systematic literatures searching and quality assessment.

Methods:

Data bases including Chinese Biomedical Literature Database

the China National Knowledge Infrastructure

Wanfang Data

China Science and Technology Journal Database were searched for published CM or integrative cardiovascular clinical practice guidelines or expert consensuses. The website www. medlive.cn was also retrieved as supplementary. The clinical practice evaluation tool AGREE Ⅱ was used to assess the quality of included guidelines or consensuses.

Results:

A total of 31 relevant clinical practice guidelines or expert consensuses were included

covering diagnosis

treatment

Chinese patent and patient fields. Common cardiovascular diseases like coronary heart diseases

heart failure and arrhythmia were also involved. Through analysis it was found that both the quantity and quality of included guidelines have been improved year by year. A total of 4 evidence-based clinical practice guideline has been found

one of which was a guideline project plan. Except that

the remaining 27 reports were all consensusbased guidelines. The scores of each field

from highest to lowest

were clarity of presentation (58%)

scope and purpose (54%)

stakeholder involvement (28%)

rigor of development (21%)

applicability (13%) and editorial independence (8%).

Conclusions:

Although clinical practice guidelines in cardiovascular domain of Chinese have gained increasing concern

with both quantity and quality improved

there is still huge gap in methodology and reporting standards between CM guidelines and international ones. On the one hand

it is essential to improve and standardize the methodology of developing CM guidelines. On the other hands

the evaluation system of evidence and recommendation with CM characters should be developed urgently.

关键词

Keywords

integrated medicineChinese medicinecardiovascular diseaseclinical practice guidelinesystematic review

references

Institute of Medicine. Clinical practice guidelines: directions for a new program. Washington (DC): National Academies Press;1990.

Institute of Medicine. Clinical practice guidelines we can trust. Washington (DC): National Academies Press; 2011.

Song J, Cheng KJ. Set clinical therapeutic guideline in traditional Medicine urgently. Chin J Integr Tradit West Med(Chin) 2006;26:581-584.

Liang WX. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. J Chin Integr Med (Chin) 2008;6:1-4.

Chen YL, Zhou Q, Cui RR, Yang N, Xiao SJ, Shang HC. Quality evaluation of traditional Chinese medicine guidelines based on AGREE Ⅱ instrument. Chin J Evid Based Med (Chin) 2016;16:1331-1337.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE next steps consortium. AGREE Ⅱ:advancing guideline development, reporting and evaluation in health care. CMAJ 2010;182:E839-842.

Wei D, Wang CY, Xiao XJ, Cheng YL, Yao L, Liang FX, et al. Interpretation of application of guideline research and assessment instrument (AGREE Ⅱ). Chin J Evid Based Pediatr (Chin) 2013;8:316-319.

Wang SC, Zhao X, Yu S, Wang L, Lin LL. Quality evaluation of evidence-based Chinese medicine clinical diagnosis and treatment guideline: the AGREE Ⅱ instrument and its application. Chin J Tradit Chin Med Pharm (Chin)2016;31:2963-2967.

China Association of Chinese Medicine. Guidelines for diagnosis and treatment of common internal diseases in Chinese medicine (symptoms in Chinese medicine). Beijing:China Press of Traditional Chinese Medicine 2008:1-44.

China Association of Chinese Medicine. Guidelines for diagnosis and treatment of common internal diseases in Chinese medicine (diseases of modern medicine).Beijing: China Press of Traditional Chinese Medicine;2008:37-39, 47-66.

Internal Medicine Branch of Cardiovascular Diseases, et al. Chinese expert consensus for the clinical application of Xuezhikang. Chin J Med (Chin) 2009;44:69-71.

China Academy of Chinese Medical Sciences. Chinese evidence-based clinical practice guideline-CM. Beijing: China Press of Traditional Chinese Medicine; 2011:227-281.

The Committee of Promoting Blood Circulation to Remove Blood Stasis, Chinese Association of the Integration of Traditional and Western Medicine. Expert consensus on the diagnosis and treatment of blood-stasis syndrome with integrated traditional Chinese and Western medicine. Chin J Integr Tradit West Med (Chin) 2011;31:839-844.

The Committee of Interventional Cardiology, China Association of Chinese Medicine, et al. Expert consensus on the CM diagnosis and treatment of pre-and-post-operative depression or anxiety with percutaneous coronary interventional therapy.Chin Circ J (Chin) 2014;29(Suppl):151-157.

The Committee of Interventional Cardiology, China Association of Chinese Medicine, et al. Expert consensus on the CM diagnosis and treatment of pectoralgia with percutaneous coronary interventional therapy. Chin Circ J(Chin) 2014; 29(Suppl):141-146.

The Committee of Interventional Cardiology, China Association of Chinese Medicine. Expert consensus on the CM diagnosis of chest stuffiness and pains with internal wind syndrome. J Tradit Chin Med (Chin) 2014;55:1528-1530.

The Committee of Integrated Traditional Chinese and Western Medicine, Chinese Medical Doctor Association,et al. Expert consensus on the diagnosis and treatment of acute myocardial infarction with integrated traditional Chinese and Western medicine. Chin J Integr Tradit West Med (Chin) 2014;34:389-395.

CM Clinical Research Alliance of Coronary Heart Disease,et al. Expert consensus on the diagnosis and treatment of chronic cardiac failure with traditional Chinese medicine. J Tradit Chin Med (Chin) 2014;55:1258-1260.

Pulmonary System Branch of China Association of Chinese Medicine. Chinese medicine guideline on the diagnosis and treatment of chronic pulmonary heart disease. J Tradit Chin Med (Chin) 2013;55:526-531.

Chinese Integrative Medicine Association Cardiology Committee Heart Failure Group, et al. Expert consensus on the normative clinic application of Xinmailong Injection for chronic cardiac failure. Chin J Integr Tradit West Med (Chin)2016;36:280-284.

The Committee of Neurology, Beijing Association of Integrative Medicine. Expert consensus on the diagnosis and treatment of acute hypertensive encephalorrhagia with integrated traditional Chinese and Western medicine. Chin Gen Prac (Chin) 2016;19:3641-3648.

Chinese Integrative Medicine Association Cardiology Committee, et al. Expert consensus on the diagnosis and treatment of chronic cardiac failure with integrated traditional Chinese and Western medicine. Chin J Integr Tradit West Med (Chin) 2016;36:133-141.

China Heart Federation, Chinese Society of Cardiovascular Prevention and Rehabilitation. Chinese expert consensus on the use of Zhibitai Capsules. Chin J Intern Med (Chin) 2017;56:628-632.

The Committee of Integrated Traditional Chinese and Western Medicine, Chinese Medical Doctor Association.Chinese expert consensus on the use of Safflower yellow.Chin J Integr Tradit West Med (Chin) 2017;37:1167-1173.

Chinese Integrative Medicine Association Cardiology Committee. Chinese expert consensus on the application of Shexiang Baoxin Pills for angina pectoris. Chin J Integr Tradit West Med (Chin) 2018;38:145-153.

Chinese Integrative Medicine Association Cerebral-Cardiac Committee, et al. Chinese expert consensus on the clinical application of Naoxintong Capsules. Chin J Integr Tradit West Med (Chin) 2017;37:1039-1042.

National Cardiovascular Disease Center, et al. Expert consensus on the Ⅰ phase cardiac rehabilitation of coronary artery bypass grafting with integrated traditional Chinese and Western medicine. Chin Circ J (Chin) 2017;32:314-317.

The Committee of Interventional Cardiology, World Federation of Chinese Medicine Societies, et al. Expert consensus on the diagnosis and treatment of percutaneous coronary intervention for perioperative myocardial damage with traditional Chinese medicine. Chin J Integr Tradit West Med (Chin) 2017;37:389-393.

Chinese Integrative Medicine Association Cardiology Committee Psychocardiology Group. Expert consensus on the diagnosis and treatment of psycho-cardiological disease with integrated traditional Chinese and Western medicine.Chin Gen Prac (Chin) 2017;20:1659-1662.

Professional Group of Lipid and Atherosclerosis, Cardiovascular Disease Committee of the Integration of Traditional Chinese and Western Medicine.Expert consensus on the diagnosis and treatment of atherosclerosis by combination of traditional Chinese and Western medicine. Chin Gen Prac (Chin) 2017;20:507-511.

Professional Group of Lipid and Atherosclerosis, Cardiovascular Disease Committee of the Integration of Traditional Chinese and Western Medicine. Expert consensus on the diagnosis and treatment of dyslipidemia by combination of traditional Chinese and Western medicine. Chin Gen Prac (Chin) 2017;20:262-269.

Li Y, Chen YL, Chen J, Shang HC, Yang KH, Guo GF, et al. Guideline protocol of non-pharmacological secondary prevention for myocardial infarction. Chin J Evid-based Med(Chin) 2016;16:617-620.

Yuan S, Li YF. The developing methodology and evaluating principle of Chinese clinical practice guidelines. Chin J Breast Dis (Electronic Edition, Chin) 2014;8:283-287.

Hu J, Zhan SY. The status quo and suggestion of Chinese clinical practice guidelines. Chin J Evid Based Cardiovasc Med (Chin) 2013;5:217-218.

Chinese Society of Cardiology of Chinese Medical Association, et al. Chinese guideline for diagnosis and treatment of heart failure 2014. Chin J Cardiol (Chin)2014;42:98-122.

State Administration of Traditional Chinese Medicine. The outline of the development plan for the standardization of traditional Chinese medicine (2006–2010). Chin News Tradit Chin Med (Chin) 2006-7-28(3).

State Administration of Traditional Chinese Medicine. The outline of the medium-and long-term development plan for the standardization of traditional Chinese medicine (2011–2020).Chin News Tradit Chin Med (Chin) 2012-12-20(3).

Wang LY, Han XJ, Shi NN, Yu WY, Lv AP. Analysis and reflection on the development of CM clinical practice guidelines. Modern Tradit Chin Med Mater Med World Sci Tech (Chin) 2011;13:728-729.

Alonso-Coello P, Irfan A, Sola I, Gich I, Delgado-Noguera M, Rigau D, et al. The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies. Qual Saf Health Care 2010;19:e58.

Chen YL, Yang KH, Marusic A, Qaseem A, Meerpohi JJ,Flottorp S, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med 2017;166:128-132.

Chen KJ, Jiang YR. Current status and problems in developing clinical guidelines for Chinese medicine and integrative medicine. J Chin Integr Med (Chin) 2009;7:301-305.

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Clinical Practice Guidelines and Experts' Consensuses for Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Chinese Herbal Medicine: A Systematic Review

Efficacy and Safety of Lianhua Qingwen for Patients with COVID-19: A Systematic Review and Meta-Analysis

Safety of Thread Embedding Acupuncture Therapy:A Systematic Review^*

Efficacy and Safety Evaluation of Taohong Siwu Decoction(桃红四物汤) for Patients with Angina Pectoris: A Meta-Analysis of Randomized Controlled Trials

Evaluation on Effectiveness and Safety of Chinese Herbs in Treatment of Sub-health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials